73 related articles for article (PubMed ID: 19679305)
1. Mast cell-dependent proteolytic modification of HDL particles during anaphylactic shock in the mouse reduces their ability to induce cholesterol efflux from macrophage foam cells ex vivo.
Judström I; Jukkola H; Metso J; Jauhiainen M; Kovanen PT; Lee-Rueckert M
Atherosclerosis; 2010 Jan; 208(1):148-54. PubMed ID: 19679305
[TBL] [Abstract][Full Text] [Related]
2. Mast cell chymase degrades apoE and apoA-II in apoA-I-knockout mouse plasma and reduces its ability to promote cellular cholesterol efflux.
Lee M; Calabresi L; Chiesa G; Franceschini G; Kovanen PT
Arterioscler Thromb Vasc Biol; 2002 Sep; 22(9):1475-81. PubMed ID: 12231569
[TBL] [Abstract][Full Text] [Related]
3. Mast cell proteases: physiological tools to study functional significance of high density lipoproteins in the initiation of reverse cholesterol transport.
Lee-Rueckert M; Kovanen PT
Atherosclerosis; 2006 Nov; 189(1):8-18. PubMed ID: 16530202
[TBL] [Abstract][Full Text] [Related]
4. Identification of domains in apoA-I susceptible to proteolysis by mast cell chymase. Implications for HDL function.
Lee M; Uboldi P; Giudice D; Catapano AL; Kovanen PT
J Lipid Res; 2000 Jun; 41(6):975-84. PubMed ID: 10828090
[TBL] [Abstract][Full Text] [Related]
5. Depletion of pre beta 1LpA1 and LpA4 particles by mast cell chymase reduces cholesterol efflux from macrophage foam cells induced by plasma.
Lee M; von Eckardstein A; Lindstedt L; Assmann G; Kovanen PT
Arterioscler Thromb Vasc Biol; 1999 Apr; 19(4):1066-74. PubMed ID: 10195937
[TBL] [Abstract][Full Text] [Related]
6. The mast cell as a pluripotent HDL-modifying effector in atherogenesis: from in vitro to in vivo significance.
Lee-Rueckert M; Kovanen PT
Curr Opin Lipidol; 2015 Oct; 26(5):362-8. PubMed ID: 26339766
[TBL] [Abstract][Full Text] [Related]
7. Chymase in exocytosed rat mast cell granules effectively proteolyzes apolipoprotein AI-containing lipoproteins, so reducing the cholesterol efflux-inducing ability of serum and aortic intimal fluid.
Lindstedt L; Lee M; Castro GR; Fruchart JC; Kovanen PT
J Clin Invest; 1996 May; 97(10):2174-82. PubMed ID: 8636396
[TBL] [Abstract][Full Text] [Related]
8. Degradation of phospholipid transfer protein (PLTP) and PLTP-generated pre-beta-high density lipoprotein by mast cell chymase impairs high affinity efflux of cholesterol from macrophage foam cells.
Lee M; Metso J; Jauhiainen M; Kovanen PT
J Biol Chem; 2003 Apr; 278(15):13539-45. PubMed ID: 12531890
[TBL] [Abstract][Full Text] [Related]
9. Extracellular modifications of HDL in vivo and the emerging concept of proteolytic inactivation of preβ-HDL.
Lee-Rueckert M; Kovanen PT
Curr Opin Lipidol; 2011 Oct; 22(5):394-402. PubMed ID: 21881503
[TBL] [Abstract][Full Text] [Related]
10. Cholesterol efflux from macrophage foam cells is enhanced by active phospholipid transfer protein through generation of two types of acceptor particles.
Vikstedt R; Metso J; Hakala J; Olkkonen VM; Ehnholm C; Jauhiainen M
Biochemistry; 2007 Oct; 46(42):11979-86. PubMed ID: 17900150
[TBL] [Abstract][Full Text] [Related]
11. Cathepsins F and S block HDL3-induced cholesterol efflux from macrophage foam cells.
Lindstedt L; Lee M; Oörni K; Brömme D; Kovanen PT
Biochem Biophys Res Commun; 2003 Dec; 312(4):1019-24. PubMed ID: 14651973
[TBL] [Abstract][Full Text] [Related]
12. Plasmin and kallikrein reduce HDL-induced cholesterol efflux from foam cells.
Lindstedt L; Kovanen PT
Biochem Biophys Res Commun; 2000 Nov; 277(3):552-7. PubMed ID: 11061992
[TBL] [Abstract][Full Text] [Related]
13. Mast cell tryptase degrades HDL and blocks its function as an acceptor of cellular cholesterol.
Lee M; Sommerhoff CP; von Eckardstein A; Zettl F; Fritz H; Kovanen PT
Arterioscler Thromb Vasc Biol; 2002 Dec; 22(12):2086-91. PubMed ID: 12482839
[TBL] [Abstract][Full Text] [Related]
14. Mast cell-mediated inhibition of reverse cholesterol transport.
Lee M; Lindstedt LK; Kovanen PT
Arterioscler Thromb; 1992 Nov; 12(11):1329-35. PubMed ID: 1420092
[TBL] [Abstract][Full Text] [Related]
15. Selective down-regulation by protein kinase C inhibitors of apolipoprotein-mediated cellular cholesterol efflux in macrophages.
Li Q; Tsujita M; Yokoyama S
Biochemistry; 1997 Oct; 36(40):12045-52. PubMed ID: 9315842
[TBL] [Abstract][Full Text] [Related]
16. Apolipoprotein composition and particle size affect HDL degradation by chymase: effect on cellular cholesterol efflux.
Lee M; Kovanen PT; Tedeschi G; Oungre E; Franceschini G; Calabresi L
J Lipid Res; 2003 Mar; 44(3):539-46. PubMed ID: 12562834
[TBL] [Abstract][Full Text] [Related]
17. The mast cell--a potential link between inflammation and cellular cholesterol deposition in atherogenesis.
Kovanen PT
Eur Heart J; 1993 Dec; 14 Suppl K():105-17. PubMed ID: 8131778
[TBL] [Abstract][Full Text] [Related]
18. Spontaneous remodeling of HDL particles at acidic pH enhances their capacity to induce cholesterol efflux from human macrophage foam cells.
Nguyen SD; Öörni K; Lee-Rueckert M; Pihlajamaa T; Metso J; Jauhiainen M; Kovanen PT
J Lipid Res; 2012 Oct; 53(10):2115-2125. PubMed ID: 22855736
[TBL] [Abstract][Full Text] [Related]
19. Mast cell activation in vivo impairs the macrophage reverse cholesterol transport pathway in the mouse.
Lee-Rueckert M; Silvennoinen R; Rotllan N; Judström I; Blanco-Vaca F; Metso J; Jauhiainen M; Kovanen PT; Escola-Gil JC
Arterioscler Thromb Vasc Biol; 2011 Mar; 31(3):520-7. PubMed ID: 21212401
[TBL] [Abstract][Full Text] [Related]
20. Role of HDL apolipoprotein E in cellular cholesterol efflux: studies in apo E knockout transgenic mice.
Hayek T; Oiknine J; Brook JG; Aviram M
Biochem Biophys Res Commun; 1994 Dec; 205(2):1072-8. PubMed ID: 7802634
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
